Vesicant Agents and Antivesicant Medical Countermeasures: Clinical Toxicology and Psychological Implications

Military Psychology

Volumn 14, Issue 2, 2002, Pages 145-157

  Smith, William J ^a  

^a US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0347016857     PISSN: 08995605     EISSN: None     Source Type: Journal    
DOI: 10.1207/S15327876MP1402_5     Document Type: Article

References (48)

1. Alexander, S. F. (1947). Medical report of the Bari Harbor mustard casualties. The Military Surgeon, 101, 1-17.
2. Balali-Mood, M. (1986). First reports of delayed toxic effects of yperite poisoning in Iranian fighters. In B. Heyndricks (Ed.), Terrorism: Analysis and detection of explosives (pp. 489-495). Ghent, Belgium: Rijksuniversiteit.
3. Balali-Mood, M. (1996). Delayed toxic effects of sulfur mustard in 1428 patients. In Proceedings of the Chemical Biological Medical Treatment Symposium: An exploration of present capabilities and future requirements (pp. 125-133). Spiez, Switzerland.
4. Cappizzi, R. L., Smith, W. J., Field, R. J., & Papirmeister, B. (1973). A host-mediated assay for chemical mutagens using the L5178Y/Asn(-) murine leukemia. Mutation Research, 21, 6.
5. Carus, W. S. (1988). Chemical weapons in the Middle East (Res. Memo No. 9:1-15). Washington, DC: Washington Institute for Near East Policy, Policy Focus.
6. Dixon, M., & Needham, D. M. (1946). Biochemical research on chemical warfare agents. Nature, 158, 512-518.
7. Easton, D. F., Peto, J., & Doll, R. (1988). Cancers of the respiratory tract in mustard gas workers. British Journal of Industrial Medicine, 45, 653-659.
8. Eisenmenger, W., Drasch, G., Von Clarmann, M., Kretschmer, E., & Roider, G. (1991). Clinical and morphological findings on mustard gas [bis(2-chloroethyl)sulfide] poisoning. Journal of Forensic Sciences, 36, 1688-1698.
9. Gross, C. L., Meier, H. L., Papirmeister, B., Brinkley, F. B., & Johnson, J. B. (1985). Sulfur mustard lowers nicotinamide dinucleotide concentrations in human skin grafted to athymic nude mice. Toxicology & Applied Pharmacology, 81, 85-90.
10. Hay, A., & Robert, G. (1990). The use of poison gas against the Iraqi Kurds: Analysis of bomb fragments, soil, and wool samples [Letter to the editor]. Journal of the American Medical Association, 263, 1065-1066.
11. Heller, C. E. (1984). Chemical warfare in World War I: The American experience, 1917-1918 (Leavenworth Papers No. 10). Fort Leavenworth, KS: Combat Studies Institute, Command and General Staff College.
12. Henlly, F. (1956). Mass intoxication due to explosion of shell containing dichloroethyl sulfide dating back to World War I. Annales de Medicine Legale, 36, 195-204.
13. Hoppmann, R. A., Peden, J. G., & Ober, S. K. (1991). Central nervous system side effects of non-steroidal anti-inflammatory drugs. Archives of Internal Medicine, 151, 1309-1313.
14. Hu, H., Cook-Deegan, R., & Shurki, A. (1989). The use of chemical weapons: Mounting an investigation using survey epidemiology. Journal of the American Medical Association, 262, 640-651.
15. Kadar, T., Amir, A., Fishbeine, E., Chapman, S., Liani, H., Sahar, R., et al. (1996). The potential therapy of steroids against ocular lesions induced by sulfur mustard vapor in rabbits. In Proceedings of the 1996 Medical Defense Bioscience Review (pp. 845-852). Aberdeen Proving Ground, MD: U.S. Army Medical Research Institute of Chemical Defense.
16. Kaufmann, M., Kahaner, K., Peselow, E. D., & Gershon, S. (1982). Steroid psychoses: Case report and brief overview. Journal of Clinical Psychiatry, 43, 75-76.
17. Krueger, G. P., & Banderet, L. E. (Eds.). (1997). Effects of chemical protective clothing on military performance [Special issue]. Military Psychology, 9(4).
18. Lohs, K. (1975). Delayed toxic effects of chemical warfare agents (SIPRI monograph). Stockholm, Sweden: Almqvist & Wilksell.
19. Martens, M. E. (1994). Hexose monophosphate shunt activity in human epidermal keratinocytes exposed to sulfur mustard. In Proceedings of the Meeting of Research Study Group-3 on Prophylaxis and Therapy Against Chemical Agents (NATO Technical Proceedings AC/243(Panel 8)TP/9, pp. 6.1-6.4). Brussels, Belgium: NATO.
20. Maumenee, A. E., & Scholz, R. O. (1948). The histopathology of the ocular lesions produced by sulfur and nitrogen mustards. Bulletin Johns Hopkins Hospital, 82, 121-147.
21. Medical management of chemical casualties handbook (3rd ed.). (1999). Aberdeen Proving Ground, MD: U.S. Army Medical Research Institute of Chemical Defense, Chemical Casualty Care Office.
22. Meier, H. L., Gross, C. L., & Papirmeister, B. (1987). 2,2′-dichlorodiethyl sulfide (sulfur mustard) decreases NAD+ levels in human leukocytes. Toxicology Letters, 39, 109-122.
23. Mol, M. A. E., Van de Ruit, A. M. B. C., & Kluivers, A. W. (1989). NAD+ levels and glucose uptake of cultured human epidermal cells exposed to sulfur mustard. Toxicology & Applied Pharmacology, 98, 159-165.
24. Momeni, A., Enshaeih, S., Meghdadi, M., & Amindjavaheri, M. (1992). Skin manifestations of mustard gas. Archives of Dermatology, 128, 775-780.
25. Moore, D. W., & Keeler, J. R. (1993). Mustard agent poisoning: Pathophysiology and nursing implications. Critical Care Nurse, 13, 62-68.
26. Papirmeister, B., Feister, A. J., Robinson, S. I., & Ford, R. D. (1991). Medical defense against mustard gas: Toxic mechanisms and pharmacological implications. Boca Raton, FL: CRC Press.
27. Papirmeister, B., Gross, C. L., Meier, H. L., Petrali, J. P., & Johnson, J. B. (1985). Molecular basis for mustard-induced vesication. Fundamental & Applied Toxicology, 5, S134-S149.
28. Pechura, C. M., & Rail, D. P. (Eds.). (1993). Veterans at risk: The health effects of mustard gas and lewisite. Washington, DC: National Academy Press.
29. Rozmiarek, J., Cappizzi, R. L., Papirmeister, B., Furman, W. H., & Smith, W. J. (1973). Mutagenic activity in somatic and germ cells following chronic inhalation of sulfur mustard. Mutation Research, 21, 13.
30. Schnurr, P. P., Green, B. L., & Friedman, M. J. (1996). Post-traumatic stress disorder among World War II mustard gas test participants. Military Medicine, 161, 131-136.
31. Schnyder, J., & Bagglionoi, M. (1980). Induction of plasminogen activator secretion in macrophages by electrochemical stimulation of the hexose monophosphate shunt by methylene blue. Proceedings of the National Academy of Science (USA), 77, 414-417.
32. Sidell, F. R., Urbanetti, J. S., Smith, W. J., & Hurst, C. G. (1997). Vesicants. In R. Zajtchuk & R. F. Bellamy (Eds.), Textbook of military medicine: Medical aspects of chemical and biological warfare (pp. 197-228). Washington, DC: Office of the Surgeon General.
33. Smith, K. J., Hurst, C. G., Moeller, R. B., Skelton, H. G., & Sidell, F. R. (1995). Sulfur mustard: Its continuing threat as a chemical warfare agent, the cutaneous lesions induced, progress in understanding its mechanism of action, its long-term health effects, and new developments for protection and therapy. Journal of the American Academy of Dermatology, 32, 765-776.
34. Smith, W. J., & Dunn, M. A. (1991). Medical defense against blistering chemical warfare agents. Archives of Dermatology, 127, 1207-1213.
35. Smith, W. J., Babin, M. C., Kiser, R. C., & Casillas, R. P. (2000). Development of medical countermeasures to sulfur mustard vesication. In Proceedings of the 22nd Army Science Conference (pp. 314-318). Washington, DC: Assistant Secretary of the Army (Acquisition, Logistics & Technology).
36. Solberg, Y., Alcalay, M., & Belkin, M. (1997). Ocular injury by mustard gas. Survey of Opthamology, 41, 461-466.
37. Stewart, M. J. (1918). Report on cases of poisoning by "mustard gas," with special reference to the histological changes and to alterations in the lymphocyte count (Rep. No. 17). London: Chemical Warfare Medical Committee.
38. Stokes, J. W., & Banderet, L. E. (1997). Psychological aspects of chemical defense and warfare. Military Psychology, 9, 395-415.
39. Thomsen, A. B., Eriksen, J., & Smit-Nielsen, K. (1998). Chronic neuropathic symptoms after exposure to mustard gas: A long-term investigation. Journal of the American Academy of Dermatology, 39, 187-190.
40. United Nations. (1984, March). Report of the specialists appointed by the Secretary-General to investigate allegations by the Islamic Republic of Iran concerning the use of chemical weapons (Rep. No. S/16513). New York: Author.
41. United Nations. (1986, March). Report of the mission dispatched by the Secretary-General to investigate allegations of the use of chemical weapons in the conflict between Iran and Iraq (Rep. No. S/17911). New York: Author.
42. United Nations. (1987, May). Report of the mission dispatched by the Secretary-General to investigate allegations of the use of chemical weapons in the conflict between the Islamic Republic of Iran and Iraq (Rep. No. S/18852). New York: Author.
43. Urbanetti, J. S. (1988). Battlefield chemical inhalation injury. In J. Loke (Ed.), Pathophysiology and treatment of inhalation injuries (pp. 281-348). New York: Marcel Dekker.
44. Vedder, E. B. (1925). The medical aspects of chemical warfare (pp. 125-166). Baltimore: Williams & Wilkins.
45. Warthin, A. S., & Weller, C. V. (1919). The medical aspects of mustard gas poisoning. St. Louis: Mosby.
46. Warthin, A. S., Weller, C. V., & Herrmann, G. R. (1918). The ocular lesions produced by dichlorethylsulphide ("mustard gas"). Journal of Laboratory & Clinical Medicine, 4, 785-832.
47. Watson, A. P., Jones, T. D., & Griffin, G. D. (1989). Sulfur mustard as a carcinogen: Application of relative potency analysis to the chemical warfare agents H, HD, and HT. Regulatory Toxicology & Pharmacology, 10, 1-25.
48. Willems, J. L. (1989). Clinical management of mustard gas casualties. Annales Medicinae Militaris Belgicae, 3(Suppl.), 1-61.